ATE397003T1 - Ruthenium(ii)-komplexe zur behandlung von tumoren - Google Patents

Ruthenium(ii)-komplexe zur behandlung von tumoren

Info

Publication number
ATE397003T1
ATE397003T1 AT04730284T AT04730284T ATE397003T1 AT E397003 T1 ATE397003 T1 AT E397003T1 AT 04730284 T AT04730284 T AT 04730284T AT 04730284 T AT04730284 T AT 04730284T AT E397003 T1 ATE397003 T1 AT E397003T1
Authority
AT
Austria
Prior art keywords
ruthenium
treatment
tumors
complexes
cancer
Prior art date
Application number
AT04730284T
Other languages
English (en)
Inventor
Abraha Habtemariam
Peter John Sadler
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Application granted granted Critical
Publication of ATE397003T1 publication Critical patent/ATE397003T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04730284T 2003-04-30 2004-04-29 Ruthenium(ii)-komplexe zur behandlung von tumoren ATE397003T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0309894 2003-04-30

Publications (1)

Publication Number Publication Date
ATE397003T1 true ATE397003T1 (de) 2008-06-15

Family

ID=33397030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730284T ATE397003T1 (de) 2003-04-30 2004-04-29 Ruthenium(ii)-komplexe zur behandlung von tumoren

Country Status (19)

Country Link
US (1) US7241913B2 (de)
EP (1) EP1618116B1 (de)
JP (1) JP2006525982A (de)
KR (1) KR20060023526A (de)
CN (1) CN100368418C (de)
AT (1) ATE397003T1 (de)
AU (1) AU2004234127A1 (de)
BR (1) BRPI0409768A (de)
CA (1) CA2523811A1 (de)
DE (1) DE602004014125D1 (de)
DK (1) DK1618116T3 (de)
ES (1) ES2308176T3 (de)
HK (1) HK1084954A1 (de)
MX (1) MXPA05011653A (de)
NO (1) NO20055650L (de)
NZ (1) NZ543184A (de)
PT (1) PT1618116E (de)
WO (1) WO2004096819A1 (de)
ZA (1) ZA200508513B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0418613D0 (en) * 2004-08-20 2004-09-22 Pugh Rhoderick Internet security system
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980473A (en) 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
DE69634639T2 (de) * 1995-12-06 2006-03-02 Japan Science And Technology Agency, Kawaguchi Verfahren zur herstellung optische aktive verbindungen
JP2003512471A (ja) 1999-10-27 2003-04-02 ユニバーシティ コート, エディンバラ大学 窒素および配位子を含む癌治療用の半サンドイッチ状ルテニウム(ii)化合物
GB0016052D0 (en) 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds

Also Published As

Publication number Publication date
CN1780845A (zh) 2006-05-31
US20060258634A1 (en) 2006-11-16
MXPA05011653A (es) 2006-06-27
PT1618116E (pt) 2008-08-18
ES2308176T3 (es) 2008-12-01
BRPI0409768A (pt) 2006-05-09
DE602004014125D1 (de) 2008-07-10
NZ543184A (en) 2008-03-28
ZA200508513B (en) 2006-07-26
WO2004096819A1 (en) 2004-11-11
CA2523811A1 (en) 2004-11-11
JP2006525982A (ja) 2006-11-16
KR20060023526A (ko) 2006-03-14
NO20055650L (no) 2006-01-19
US7241913B2 (en) 2007-07-10
HK1084954A1 (en) 2006-08-11
EP1618116A1 (de) 2006-01-25
CN100368418C (zh) 2008-02-13
EP1618116B1 (de) 2008-05-28
AU2004234127A1 (en) 2004-11-11
NO20055650D0 (no) 2005-11-30
DK1618116T3 (da) 2008-09-08

Similar Documents

Publication Publication Date Title
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
NO20050640L (no) Rutenium anticancer komplekser
YU21401A (sh) Tetrahidropiridoetri
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
NO20055650D0 (no) Ruteinum (II)-komplekser for behandling av tumorer
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
ATE435647T1 (de) Rutheniumkomplexe zur krebsbehandlung
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE519740T1 (de) Tetrahydroindolderivate zur behandlung von alzheimer-krankheit
BRPI0415355A (pt) triarilimidazóis
PT1606233E (pt) Derivados de esteres lipidicos de nucleotidos
DE602004003829D1 (de) 2-ä4-(phenylamino)-piperidin-1-ylü-n-phenyl-acetamid derivate und verwandte verbindungen als neuropeptid y5 (npy5) liganden zur behandlung von fettleibigkeit
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE412411T1 (de) Pmcol zur behandlung von prostatakrebs
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
MXPA05008293A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE411313T1 (de) Neue makrocyclen zur behandlung von krebserkrankungen
DE50200757D1 (de) Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren
ATE431348T1 (de) Thiaepothilone zur behandlung von krebserkrankungen
ATE476185T1 (de) Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
ATE387913T1 (de) Xenogene oligo- oder/und polyribonukleotide als mittel zur behandlung von malignen tumoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1618116

Country of ref document: EP

REN Ceased due to non-payment of the annual fee